Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02892201
Title Pembrolizumab in HNSCC With Residual Disease After Radiation
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Yale University
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Yale Cancer Center New Haven Connecticut 06520 United States Details
University of Texas Southwestern Medical Center (UTSW) Dallas Texas 75390 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field